News
NELA BioDynamics in Top 10 MedTech Startups in Europe 2021
MedTech Outlook, one of the main digital magazines specialized in the health sector, has selected us as one of the Top 10 startups in MedTech 2021 in Europe that will impact the industry. Read the full post here This award is a recognition of the work and effort made...
The Ministry of Science and Innovation grants NELA BioDynamics the seal of innovative SME
NELA BioDynamics team is pleased to announce that it has obtained the Innovative SME seal awarded by the Spanish Ministry of Science and Innovation, for its breakthrough project for the development of a disruptive Intramedullary implant for hip and other joint...
NELA BioDynamics achieves promising results in pilot biological study
NELA continues to advance in the development of its implant, achieving promising results in a pilot test in sheep, aiming to obtain preliminary histological data. The results showed a significant improvement in the host’s tolerability to the implant, evidenced due to...
NELA BioDynamics has received financing by ENISA
We are pleased to announce that NELA has been financed by ENISA in the form of participatory loan through ENISA Entrepreneurs line, directed to companies with a clear competitive advantage. This financial support will allow us to continue the pre-clinical activities...
NELA BioDynamics in Valencia Plaza newspaper
The digital newspaper Valencia Plaza published a press release about NELA BioDynamics, echoing our technology and current investment round. The full post can be read here:...
NELA BioDynamics project obtained a grant from CDTI
NELA BioDynamics obtains funding from CDTI through the NEOTEC 2020 call for the development of high-impact and innovative business projects. The CAMINA project: DEVELOPMENT OF A DISRUPTIVE ENDOMEDULAR IMPLANT FOR THE REPLACEMENT OF THE HIP AND OTHER JOINTS (EXP code -...
NELA BioDynamics will participate in this year’s Accelerator Meeting Point (AMP III) organized by IDIBELL.
The AMP III will take place on 26th November 2020, it is organized by IDIBELL’s Business Development & Innovation Area and aims to offer investors preferential access to innovation projects in different stages of development. This third edition has been...
Oriel STAT A MATRIX chosen as USA and EU regulatory consultants by NELA BioDynamics.
Oriel, together with NELA’s regulatory team, will be in charge of defining the regulatory strategy for both the US and EU markets, including necessary meetings with either the FDA or Notified Body as part of the approval/certification process. Oriel STAT A MATRIX is a...
NELA BioDynamics partners with IGTP on pre-clinical studies to evaluate its innovative hip replacement prosthesis.
NELA's team ready for surgery at the Center for Comparative Medicine and Bioimage (CMCiB). NELA BioDynamic, a pre-clinical stage medical device company focused on the development of next generation orthopedic devices, announced today that it is launching a research...
NELA BioDynamics wins best Health & Bio Startup Prize from Valencia Startup Association.
The Oceanogràfic Valencia hosted last year one of the great events of the Valencian entrepreneurial ecosystem: the 'Valencia Startup Awards', an event that has awarded prizes to the best startup, the best entrepreneur and the best sectorial startup of the year. In...